Disease–drug interaction: Reduced response to propranolol despite increased concentration in the rat with inflammation
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (5) , 1077-1084
- https://doi.org/10.1002/jps.10381
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Drug-disease interactions: reduced β-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the ratBritish Journal of Pharmacology, 2001
- Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritisBritish Journal of Clinical Pharmacology, 2000
- MODULATION OF DRUG METABOLISM IN INFECTIOUS AND INFLAMMATORY DISEASES*Drug Metabolism Reviews, 1999
- Regulation of Cytochromes P450 During Inflammation and InfectionDrug Metabolism Reviews, 1997
- Effect of Graded Hypoxia on the Induction and Function of Inducible Nitric Oxide Synthase in Rat Mesangial CellsCirculation Research, 1995
- Stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil: Species differences and influence of endotoxinChirality, 1995
- Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the ratChirality, 1994
- Selective Effect of Adjuvant Arthritis on the Disposition of Propranolol Enantiomers in Rats Detected Using a Stereospecific HPLC AssayPharmaceutical Research, 1993
- Binding to serum α1‐acid glycoprotein and effect of β‐adrenoceptor antagonists in rats with inflammationBritish Journal of Pharmacology, 1986
- β-Blocker Plasma Concentrations and Inflammatory DiseaseClinical Pharmacokinetics, 1982